PDCD1 and glioblastoma: Despite the increased T-cell infiltration and remodeling of the GBM microenvironment observed after neoadjuvant anti-PD-1 treatment, the main immune cells infiltrating the GBM microenvironment are still macrophages and monocytes [45].